Pyxis Oncology Ownership | Who Owns Pyxis Oncology?
Pyxis Oncology Ownership Summary
Pyxis Oncology is owned by 45.93% institutional investors, 24.54% insiders, and 29.53% retail investors. Deep track capital, lp is the largest institutional shareholder, holding 8.16% of PYXS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.18% of its assets in Pyxis Oncology shares.
PYXS Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Pyxis Oncology | 45.93% | 24.54% | 29.53% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Deep track capital, lp | 4.18M | 8.16% | $13.85M |
Laurion capital management lp | 3.86M | 7.53% | $12.78M |
Blackrock | 2.79M | 5.43% | $9.22M |
Balyasny asset management | 2.56M | 5.00% | $8.48M |
Vanguard group | 2.06M | 4.02% | $6.82M |
Stempoint capital lp | 1.20M | 2.34% | $3.98M |
Blue owl capital lp | 1.05M | 2.04% | $3.46M |
Geode capital management | 1.03M | 2.00% | $3.40M |
State street | 742.91K | 1.45% | $2.46M |
Abrdn | 708.30K | 1.38% | $2.34M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Stempoint capital lp | 1.20M | 1.17% | $3.98M |
Blue owl capital lp | 1.05M | 0.96% | $3.46M |
Deep track capital, lp | 4.18M | 0.41% | $13.85M |
Decheng capital | 326.81K | 0.33% | $1.08M |
Yu fan | 69.30K | 0.30% | $229.39K |
Cable car capital | 61.61K | 0.21% | $203.92K |
Ikarian capital | 3.59K | 0.21% | $1.19M |
Laurion capital management lp | 3.86M | 0.15% | $12.78M |
University of chicago | 48.73K | 0.12% | $161.30K |
Pier 88 investment partners | 113.70K | 0.08% | $376.35K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 2.79M | 0.00% | 2.46M |
Blue owl capital lp | 1.05M | 0.96% | 1.05M |
Geode capital management | 1.03M | 0.00% | 687.59K |
Vanguard group | 2.06M | 0.00% | 659.02K |
State street | 742.91K | 0.00% | 633.55K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Stempoint capital lp | 1.20M | 1.17% | -591.52K |
Superstring capital management lp | - | - | -484.44K |
Monashee investment management | - | - | -442.50K |
Goldman sachs group | 117.25K | 0.00% | -219.44K |
Jane street group | 35.21K | - | -140.04K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Blue owl capital lp | 1.05M | 0.96% | 1.05M | $3.46M |
Nuveen asset management | 149.02K | 0.00% | 149.02K | $493.27K |
Boothbay fund management | 99.10K | 0.01% | 99.10K | $328.02K |
Rhumbline advisers | 65.29K | 0.00% | 65.29K | $216.09K |
Simplex trading | 40.76K | 0.00% | 40.76K | $134.00K |
Sold Out
Holder | Change |
---|---|
Fmr | -1.00 |
West branch capital | -25.00 |
Allworth financial lp | -200.00 |
Macquarie group | -1.11K |
Redwood wealth management group | -1.40K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 99 | 19.28% | 27,885,908 | -0.82% | 45 | 1.53% | 54 | 22.73% | 15 | -37.50% |
Jun 30, 2024 | 83 | 9.21% | 28,117,599 | 22.50% | 54 | 2.08% | 44 | -18.52% | 24 | 500.00% |
Mar 31, 2024 | 76 | 46.15% | 22,952,291 | 161.33% | 51 | 11.36% | 54 | 200.00% | 4 | -63.64% |
Dec 31, 2023 | 52 | 4.00% | 8,782,945 | 13.39% | 21 | 5.22% | 18 | -30.77% | 11 | -15.38% |
Sep 30, 2023 | 50 | 6.38% | 7,745,767 | -19.36% | 20 | 2.73% | 26 | -23.53% | 13 | 116.67% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 1.29M | 2.18% | - |
iShares Russell 2000 ETF | 1.23M | 2.07% | -2.77K |
Vanguard Institutional Extnd Mkt Idx Tr | 782.88K | 1.32% | - |
HBM Healthcare Investments AG Ord | 717.82K | 1.21% | - |
abrdn Healthcare Investors | 626.64K | 1.05% | - |
Fidelity Small Cap Index | 500.44K | 0.84% | -12.49K |
iShares Russell 2000 Value ETF | 492.03K | 0.83% | - |
State St Russell Sm/Mid Cp® Indx NL Cl C | 287.79K | 0.48% | -10.00K |
abrdn Life Sciences Investors | 286.41K | 0.48% | - |
Fidelity Extended Market Index | 264.30K | 0.44% | -9.84K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 26, 2024 | Connealy Pamela Ann | CFO & COO | Buy | $10.90K |
Nov 26, 2024 | Connealy Pamela Ann | CFO & COO | Buy | $163.46K |
Sep 28, 2023 | Connealy Pamela Ann | CFO and COO | Buy | $14.96K |
Sep 27, 2023 | Wadhane Jitendra | Chief Accounting Officer | Buy | $4.67K |
Sep 27, 2023 | Connealy Pamela Ann | CFO and COO | Buy | $11.87K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | 2 | - |
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q4 | - | - |
2023 Q3 | 7 | 5 |
PYXS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools